Gunther Glehr - Publications

Plasma Proteomics Predicts Late Kidney Graft Failure Independently From Clinical Parameters.

Journal: Transplantation

Published: April 15, 2026

Expanding the supply of human leukocytes for research by harvesting cell concentrates from Trima Accel tubing sets.

Journal: Scientific reports

Published: March 16, 2026

Liver transplant allocation by milan criteria may exclude eligible HCC patients without survival benefit - a post-hoc analysis of the SiLVER study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 24, 2026

Superior precision of clinical predictions after CD3-relativisation to align flow cytometry data.

Journal: EBioMedicine

Published: October 17, 2025

Soluble CD46 improves detection of hepatic steatosis by contrast-enhanced computed tomography before liver surgery.

Journal: International journal of surgery (London, England)

Published: February 15, 2025

Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy.

Journal: Cancer cell international

Published: January 14, 2025

Proteolytic shedding of CD46 from human hepatocytes indicates liver stress.

Journal: Heliyon

Published: June 20, 2024

Intraoperative contrast-enhanced ultrasound has an outcome-relevant impact on surgery of primary and metastatic liver lesions.

Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)

Published: February 09, 2024

Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection.

Journal: Antibiotics (Basel, Switzerland)

Published: January 10, 2024

Soluble CD46 as a diagnostic marker of hepatic steatosis.

Journal: EBioMedicine

Published: January 05, 2024

Restricting datasets to classifiable samples augments discovery of immune disease biomarkers.

Journal: Nature communications

Published: May 04, 2023

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition.

Journal: Frontiers in immunology

Published: August 03, 2022